Medically reviewed by Gagandeep Brar, MD Key Takeaways ITP does not increase the risk of getting or having severe ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Immune Thrombocytopenia Market ...

Cerebral venous sinus thrombosis (CVST) with thrombocytopenia is characterized by a blood clot in the brain and a platelet count that’s lower than normal. Prompt medical attention is crucial to lower ...

Zydus Lifesciences receives USFDA approval for generic Eltrombopag tablets, treating thrombocytopenia (low platelet count).

A low platelet count—also called thrombocytopenia—means your blood has fewer than 150,000 platelets per microliter. Platelets are cells that help your blood clot. Without enough platelets, your body ...

The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.

Megakaryocytes, which are derived from hematopoietic stem cell precursors in bone marrow, form and release platelets; these circulate in the blood for 8 to 10 days before they are removed by hepatic ...

The Food and Drug Administration has approved Yartemlea ® (narsoplimab-wuug) for the treatment of adult and pediatric patients aged 2 years and older with hematopoietic stem cell transplant ...